Circulating Tumor DNA
Circulating Tumor DNA
Recruiting · NCT06923527 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Circulating Tumor DNA | estrogen-receptor positive breast cancer | Recruiting | Phase 2 | 2026-09-21 | NCT06923527 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Johns Hopkins University | 579 |
| Personalis Inc. | 6 |
| Stemline Therapeutics, Inc. | 22 |
| Yale University | 458 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Lombardi Comprehensive Cancer Center at Georgetown University Medical Center | Washington D.C. | United States | 3 |
| Montefiore Einstein Comprehensive Cancer Center | The Bronx | United States | 9 |
| Sidney Kimmel Comprehensive Cancer Center at John Hopkins | Baltimore | United States | 2 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |
| Yale University | New Haven | United States | 76 |